Global Food Allergy Immunotherapies Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Food Allergy Immunotherapies market report explains the definition, types, applications, major countries, and major players of the Food Allergy Immunotherapies market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Leti Pharma

    • Stallergenes Greer

    • HAL Allergy Group

    • Merck KGaA (Allergopharma)

    • Allovate, LLC

    • Torii Pharmaceutical Co, Ltd

    • Biomay AG

    • ALK-Abello A/S

    • Allergy Therapeutics

    • Jubliant Pharma (Hollister Allergy)

    By Type:

    • Subcutaneous Immunotherapy

    • Sublingual Immunotherapy

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Food Allergy Immunotherapies Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Food Allergy Immunotherapies Outlook to 2028- Original Forecasts

    • 2.2 Food Allergy Immunotherapies Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Food Allergy Immunotherapies Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Food Allergy Immunotherapies Market- Recent Developments

    • 6.1 Food Allergy Immunotherapies Market News and Developments

    • 6.2 Food Allergy Immunotherapies Market Deals Landscape

    7 Food Allergy Immunotherapies Raw Materials and Cost Structure Analysis

    • 7.1 Food Allergy Immunotherapies Key Raw Materials

    • 7.2 Food Allergy Immunotherapies Price Trend of Key Raw Materials

    • 7.3 Food Allergy Immunotherapies Key Suppliers of Raw Materials

    • 7.4 Food Allergy Immunotherapies Market Concentration Rate of Raw Materials

    • 7.5 Food Allergy Immunotherapies Cost Structure Analysis

      • 7.5.1 Food Allergy Immunotherapies Raw Materials Analysis

      • 7.5.2 Food Allergy Immunotherapies Labor Cost Analysis

      • 7.5.3 Food Allergy Immunotherapies Manufacturing Expenses Analysis

    8 Global Food Allergy Immunotherapies Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Food Allergy Immunotherapies Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Food Allergy Immunotherapies Export by Region (Top 10 Countries) (2017-2028)

    9 Global Food Allergy Immunotherapies Market Outlook by Types and Applications to 2022

    • 9.1 Global Food Allergy Immunotherapies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Food Allergy Immunotherapies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Food Allergy Immunotherapies Market Analysis and Outlook till 2022

    • 10.1 Global Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.2.2 Canada Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.2.3 Mexico Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.2 UK Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.3 Spain Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.4 Belgium Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.5 France Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.6 Italy Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.7 Denmark Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.8 Finland Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.9 Norway Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.10 Sweden Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.11 Poland Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.12 Russia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.3.13 Turkey Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.2 Japan Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.3 India Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.4 South Korea Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.5 Pakistan Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.6 Bangladesh Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.7 Indonesia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.8 Thailand Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.9 Singapore Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.10 Malaysia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.11 Philippines Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.4.12 Vietnam Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.2 Colombia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.3 Chile Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.4 Argentina Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.5 Venezuela Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.6 Peru Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.7 Puerto Rico Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.5.8 Ecuador Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.6.2 Kuwait Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.6.3 Oman Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.6.4 Qatar Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.7.2 South Africa Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.7.3 Egypt Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.7.4 Algeria Food Allergy Immunotherapies Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Food Allergy Immunotherapies Consumption (2017-2022)

      • 10.8.2 New Zealand Food Allergy Immunotherapies Consumption (2017-2022)

    11 Global Food Allergy Immunotherapies Competitive Analysis

    • 11.1 Leti Pharma

      • 11.1.1 Leti Pharma Company Details

      • 11.1.2 Leti Pharma Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Leti Pharma Food Allergy Immunotherapies Main Business and Markets Served

      • 11.1.4 Leti Pharma Food Allergy Immunotherapies Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Stallergenes Greer

      • 11.2.1 Stallergenes Greer Company Details

      • 11.2.2 Stallergenes Greer Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Stallergenes Greer Food Allergy Immunotherapies Main Business and Markets Served

      • 11.2.4 Stallergenes Greer Food Allergy Immunotherapies Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 HAL Allergy Group

      • 11.3.1 HAL Allergy Group Company Details

      • 11.3.2 HAL Allergy Group Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 HAL Allergy Group Food Allergy Immunotherapies Main Business and Markets Served

      • 11.3.4 HAL Allergy Group Food Allergy Immunotherapies Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck KGaA (Allergopharma)

      • 11.4.1 Merck KGaA (Allergopharma) Company Details

      • 11.4.2 Merck KGaA (Allergopharma) Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck KGaA (Allergopharma) Food Allergy Immunotherapies Main Business and Markets Served

      • 11.4.4 Merck KGaA (Allergopharma) Food Allergy Immunotherapies Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Allovate, LLC

      • 11.5.1 Allovate, LLC Company Details

      • 11.5.2 Allovate, LLC Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Allovate, LLC Food Allergy Immunotherapies Main Business and Markets Served

      • 11.5.4 Allovate, LLC Food Allergy Immunotherapies Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Torii Pharmaceutical Co, Ltd

      • 11.6.1 Torii Pharmaceutical Co, Ltd Company Details

      • 11.6.2 Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Main Business and Markets Served

      • 11.6.4 Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Biomay AG

      • 11.7.1 Biomay AG Company Details

      • 11.7.2 Biomay AG Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Biomay AG Food Allergy Immunotherapies Main Business and Markets Served

      • 11.7.4 Biomay AG Food Allergy Immunotherapies Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 ALK-Abello A/S

      • 11.8.1 ALK-Abello A/S Company Details

      • 11.8.2 ALK-Abello A/S Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 ALK-Abello A/S Food Allergy Immunotherapies Main Business and Markets Served

      • 11.8.4 ALK-Abello A/S Food Allergy Immunotherapies Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Allergy Therapeutics

      • 11.9.1 Allergy Therapeutics Company Details

      • 11.9.2 Allergy Therapeutics Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Allergy Therapeutics Food Allergy Immunotherapies Main Business and Markets Served

      • 11.9.4 Allergy Therapeutics Food Allergy Immunotherapies Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Jubliant Pharma (Hollister Allergy)

      • 11.10.1 Jubliant Pharma (Hollister Allergy) Company Details

      • 11.10.2 Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Main Business and Markets Served

      • 11.10.4 Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Food Allergy Immunotherapies Market Outlook by Types and Applications to 2028

    • 12.1 Global Food Allergy Immunotherapies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Food Allergy Immunotherapies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Food Allergy Immunotherapies Market Analysis and Outlook to 2028

    • 13.1 Global Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.2.2 Canada Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.2 UK Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.3 Spain Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.5 France Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.6 Italy Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.8 Finland Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.9 Norway Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.11 Poland Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.12 Russia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.2 Japan Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.3 India Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.3 Chile Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.6 Peru Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.6.3 Oman Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Food Allergy Immunotherapies Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Food Allergy Immunotherapies Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Food Allergy Immunotherapies

    • Figure of Food Allergy Immunotherapies Picture

    • Table Global Food Allergy Immunotherapies Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Food Allergy Immunotherapies Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Sublingual Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Table North America Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure United States Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Canada Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Mexico Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table Europe Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure Germany Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure UK Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Spain Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Belgium Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure France Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Italy Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Denmark Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Finland Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Norway Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Sweden Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Poland Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Russia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Turkey Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table APAC Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure China Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Japan Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure India Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Thailand Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Singapore Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Philippines Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table South America Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure Brazil Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Colombia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Chile Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Argentina Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Peru Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table GCC Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure Bahrain Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Oman Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Qatar Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table Africa Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure Nigeria Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure South Africa Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Egypt Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure Algeria Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table Oceania Food Allergy Immunotherapies Consumption by Country (2017-2022)

    • Figure Australia Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Food Allergy Immunotherapies Consumption and Growth Rate (2017-2022)

    • Table Leti Pharma Company Details

    • Table Leti Pharma Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Leti Pharma Food Allergy Immunotherapies Main Business and Markets Served

    • Table Leti Pharma Food Allergy Immunotherapies Product Portfolio

    • Table Stallergenes Greer Company Details

    • Table Stallergenes Greer Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stallergenes Greer Food Allergy Immunotherapies Main Business and Markets Served

    • Table Stallergenes Greer Food Allergy Immunotherapies Product Portfolio

    • Table HAL Allergy Group Company Details

    • Table HAL Allergy Group Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table HAL Allergy Group Food Allergy Immunotherapies Main Business and Markets Served

    • Table HAL Allergy Group Food Allergy Immunotherapies Product Portfolio

    • Table Merck KGaA (Allergopharma) Company Details

    • Table Merck KGaA (Allergopharma) Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA (Allergopharma) Food Allergy Immunotherapies Main Business and Markets Served

    • Table Merck KGaA (Allergopharma) Food Allergy Immunotherapies Product Portfolio

    • Table Allovate, LLC Company Details

    • Table Allovate, LLC Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allovate, LLC Food Allergy Immunotherapies Main Business and Markets Served

    • Table Allovate, LLC Food Allergy Immunotherapies Product Portfolio

    • Table Torii Pharmaceutical Co, Ltd Company Details

    • Table Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Main Business and Markets Served

    • Table Torii Pharmaceutical Co, Ltd Food Allergy Immunotherapies Product Portfolio

    • Table Biomay AG Company Details

    • Table Biomay AG Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomay AG Food Allergy Immunotherapies Main Business and Markets Served

    • Table Biomay AG Food Allergy Immunotherapies Product Portfolio

    • Table ALK-Abello A/S Company Details

    • Table ALK-Abello A/S Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALK-Abello A/S Food Allergy Immunotherapies Main Business and Markets Served

    • Table ALK-Abello A/S Food Allergy Immunotherapies Product Portfolio

    • Table Allergy Therapeutics Company Details

    • Table Allergy Therapeutics Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergy Therapeutics Food Allergy Immunotherapies Main Business and Markets Served

    • Table Allergy Therapeutics Food Allergy Immunotherapies Product Portfolio

    • Table Jubliant Pharma (Hollister Allergy) Company Details

    • Table Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Main Business and Markets Served

    • Table Jubliant Pharma (Hollister Allergy) Food Allergy Immunotherapies Product Portfolio

    • Figure Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sublingual Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Table North America Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure United States Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure Germany Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure China Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure Brazil Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Food Allergy Immunotherapies Consumption Forecast by Country (2022-2028)

    • Figure Australia Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Food Allergy Immunotherapies Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.